Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eton Pharmaceuticals (ETON) Other financing activities: 2018-2023

Historic Other financing activities for Eton Pharmaceuticals (ETON) over the last 5 years, with Dec 2023 value amounting to $180,000.

  • Eton Pharmaceuticals' Other financing activities was N/A to -$1,000 in Q4 2023 from the same period last year, while for Dec 2023 it was $2.1 million, marking a year-over-year change of. This contributed to the annual value of $180,000 for FY2023, which is N/A change from last year.
  • Latest data reveals that Eton Pharmaceuticals reported Other financing activities of $180,000 as of FY2023, which was down 94.68% from $3.4 million recorded in FY2021.
  • Eton Pharmaceuticals' Other financing activities' 5-year high stood at $3.4 million during FY2021, with a 5-year trough of $180,000 in FY2023.
  • In the last 2 years, Eton Pharmaceuticals' Other financing activities had a median value of $1.8 million in 2021 and averaged $1.8 million.
  • Data for Eton Pharmaceuticals' Other financing activities shows a peak YoY skyrocketed of 36.44% (in 2020) over the last 5 years.
  • Eton Pharmaceuticals' Other financing activities (Yearly) stood at $1.9 million in 2019, then spiked by 36.44% to $2.6 million in 2020, then surged by 31.25% to $3.4 million in 2021, then reached $180,000 in 2023.